GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 19 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $109,000 | +0.9% | 12,000 | 0.0% | 0.02% | -4.8% |
| Q3 2017 | $108,000 | +45.9% | 12,000 | 0.0% | 0.02% | +40.0% |
| Q2 2017 | $74,000 | +27.6% | 12,000 | 0.0% | 0.02% | +25.0% |
| Q1 2017 | $58,000 | +38.1% | 12,000 | 0.0% | 0.01% | +33.3% |
| Q4 2016 | $42,000 | -20.8% | 12,000 | 0.0% | 0.01% | -30.8% |
| Q3 2016 | $53,000 | -1.9% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $54,000 | -8.5% | 12,000 | 0.0% | 0.01% | -13.3% |
| Q1 2016 | $59,000 | -35.2% | 12,000 | 0.0% | 0.02% | -31.8% |
| Q4 2015 | $91,000 | +2.2% | 12,000 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $89,000 | -26.4% | 12,000 | 0.0% | 0.02% | -24.1% |
| Q2 2015 | $121,000 | +7.1% | 12,000 | 0.0% | 0.03% | +7.4% |
| Q1 2015 | $113,000 | +94.8% | 12,000 | +20.0% | 0.03% | +92.9% |
| Q4 2014 | $58,000 | +241.2% | 10,000 | +400.0% | 0.01% | +250.0% |
| Q3 2014 | $17,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|